Why These 15 Healthcare Stocks Are Surging in 2025

Page 8 of 14

7. 908 Devices Inc (NASDAQ:MASS)

Number of Hedge Fund Holders In Q4 2024: 9

908 Devices Inc (NASDAQ:MASS) creates handheld and desktop devices for chemical analysis, focusing on applications in forensics, drug detection, and public safety.

The most important catalyst was the March 2025 announcement of a strategic transformation, where 908 Devices divested its desktop bioprocessing portfolio to Repligen for $70 million.

This move sharpened the company’s focus on its higher-growth handheld market and nearly doubled its cash reserves. The company also completed the acquisition of RedWave Technology in April 2024, and integrated FTIR products to strengthen its analytical device portfolio, and reported a 19% year-over-year revenue increase for 2024, with fourth quarter revenue up 31%.

Management raised its 2025 outlook, projecting 11% to 15% revenue growth and forecasting positive adjusted EBITDA by the end of 2025, with cash flow positivity expected in 2026. In April 2025, 908 Devices received a $2 million order from the Texas Department of Public Safety for drug detection tools.

The consensus price target of $5.33 implies 1.42% downside.

MASS stock is up 145.91% year-to-date.

Page 8 of 14